Layoff
Cuts 30 jobs
Disc Medicine is laying off about 20% of staff, mainly commercial roles, after an FDA rejection.
Latest announcement (Mar 5, 2026): Disc Medicine is laying off about 20% of staff, mainly commercial roles, after an FDA rejection. The tracker lists 1 announcement for Disc Medicine since 2026, with 30 jobs reported affected. Our coverage: Biotech Layoffs Surge: Theravance Halves Staff, BioAtla Cuts 70%
Last updated Oct 2, 2026

Disc Medicine at a glance
Jobs affected are as reported by each source, summed over the 1 of 1 announcements that state a number.
Latest announcement
1 announcement · 30 jobs reported affected
Layoff
Disc Medicine is laying off about 20% of staff, mainly commercial roles, after an FDA rejection.

Free to reuse with attribution to Metaintro
Every published announcement, all years, one row per event. Column names are stable, and jobs affected are blank where no source states a number.
Show Disc Medicine's layoff history on your site. The frame updates itself as the tracker does. The credit link to Metaintro sits inside the frame and below it, so it stays even where a site removes frames.
Jobs affected are counted only when a source states a number; “Not stated” means none was disclosed. Methodology, sources and how to cite
Built for career movement
Metaintro matches you to open roles across 50M jobs, so your next application goes to a team that is hiring.